科研之友
微信
新浪微博
Facebook
分享链接
摘要
The DAWN2 (TM) study aims to improve the understanding of problems and unmet needs of people with diabetes and their family members, as well as healthcare professionals, patient organizations, and key stakeholders in diabetes. This article reports the results for the German study population and compares them to the global results. A total of 8596 people with diabetes participated in the global DAWN2 (TM) study which was conducted in 17 countries representing 4 continents. Per country about 500 people with diabetes participated in the trial. The German study population comprised 502 people with diabetes (80 people with type 1 diabetes, 422 people with type 2 diabetes). Validated questionnaires for standardized measurement of quality of life, diabetes-related distress, diabetes self-care activities, empowerment, and healthcare provision were used. Additional items, e.g. social discrimination, were included. Compared to the general population in Germany, people with diabetes reported a reduced quality of life and emotional well-being. Dispite this negative impact of diabetes on the quality of life, psychosocial aspects are rarely integrated in routine diabetes care. Nevertheless, compared to global results, the German results show a high satisfaction with diabetes care in general and a high rate of diabetes education. The extent of social discrimination is notably high, but lower than in the global comparison. The DAWN2 (TM) study reveals that diabetes is associated with significant psychosocial burden. There is a need for improvement in psychosocial care for people with diabetes. Universal Trial Number (UTN): U1111-1123-7509; Clinical Trials gov Identifier (NCT): NCT01507116.
- 出版日期2015-5
